Trials / Completed
CompletedNCT02819297
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,020 (actual)
- Sponsor
- Braintree Laboratories · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate a daily dose of BLI400 Laxative for safety and efficacy versus placebo in constipated adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BLI400 Laxative | 21 gm BLI400 powder |
| DRUG | BLI400 Placebo | Equivalent amount of placebo powder |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2016-06-30
- Last updated
- 2020-07-27
- Results posted
- 2020-06-26
Locations
51 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02819297. Inclusion in this directory is not an endorsement.